ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2015 American Transplant Congress » Concurrent Session: Liver: Immunosuppression and Rejection

Date: Tuesday, May 5, 2015

Time: 2:15pm-3:45pm

Location: Room 120-ABC

Session Type: Concurrent Session

Meeting: 2015 American Transplant Congress

2:15pm-2:27pm
Combination of Non-HLA and HLA-DSA Antibodies Identifies Liver Transplants Recipients With Highest Risk for Fibrosis Progression and Mortality

J. O'Leary,1 J. Cai,2 H. Heidecke,3 L. Jennings,1 A. Philippe,4 V. Harbour,1 R. Catar,4 P. Terasaki,2 G. Klintmalm,1 D. Dragun.4

2:27pm-2:39pm
Everolimus and Early Calcineurin Inhibitor Withdrawal Is Associated With Superior Renal Function: 5-Year Follow-Up of the Randomized PROTECT Liver Transplantation Study

M. Sterneck, G. Kaiser, N. Heyne, N. Richter, F. Rauchfuss, A. Pascher, P. Schemmer, L. Fischer, C. Klein, S. Nadalin, F. Lehner, U. Settmacher, D. Gotthardt, M. Loss, S. Ladenburger, P. Wimmer, M. Dworak, H. Schlitt.

2:39pm-2:51pm
The Impact of Acute Rejection on Liver Transplant Survival in the New Millennium

J. Levitsky,1 S. Forney,2 B. Gillespie,3 R. Merion,2,3 A. Lok,3 G. Levy,4 L. Kulik,1 M. Abecassis,1 A. Shaked.5

2:51pm-3:03pm
Rabbit Antithymocyte Globulin Is Associated With Improved Patient and Graft Survival in Liver Transplantation. Experience With 595 Patients

M. Montenovo,1 F. Jalikis,2 L. Meng,3 Y. Matthew,2 D. Andre,1 H. Ryan,3 R. Jorge.1

3:03pm-3:15pm
Everolimus Initiation Immediately After Liver Transplantation: A Single-Center Experience

U. Herden, A. Galante, S. Pischke, L. Fischer, J. Li, M. Koch, E. Achilles, B. Nashan, M. Sterneck.

3:15pm-3:27pm
Bridging Therapy With Belatacept in High MELD Liver Transplant Recipients

T. Sparkes,1 B. Masters,1 S. Hanish,2 D. Potosky,2 W. Hutson,2 J. LaMattina,2 R. Barth.2

3:27pm-3:39pm
Outcomes Between ABO-Incompatible Living Donor Liver Transplantation (LDLT) and ABO-Compatible LDLT: A Matched Study

J. Kim, S. Lee, W. Cho, J.-Y. Choi, G.-S. Choi, J. Park, C. Kwon, S. Kim, J.-W. Joh, S.-K. Lee.

« View all sessions from the 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences